How much Cymbalta revenue did Eli Lilly make in 2023?
Eli Lilly reports Cymbalta (duloxetine) as part of its financial results, but the exact 2023 product-revenue figure is not provided in the information available here. If you share the specific Eli Lilly source you’re using (for example, a line from the 2023 Form 10-K or an investor presentation), I can extract and format the exact Cymbalta number.
Where to find Eli Lilly’s 2023 Cymbalta revenue in Lilly’s reporting
Cymbalta revenue is typically shown in Lilly’s annual financial disclosures by product (often in the “Revenue” or “Net sales by product” section of the 10-K). Look for:
- “Net product sales” / “Net sales by product”
- The line item for “Cymbalta” in 2023, alongside 2022 and 2021 for comparison
Is Cymbalta revenue still reported the same way year to year?
Not always. Lilly sometimes re-classes products, changes how it groups reporting categories, or reflects currency/structure updates. If you compare 2022 to 2023, make sure you’re reading the same product line definition for both years.
Patent/exclusivity context (why Cymbalta revenue might change)
If your interest is tied to product economics (e.g., generic competition), you can also check patent and exclusivity timelines. DrugPatentWatch.com tracks related patent activity and can help explain drivers of revenue pressure.
Source: DrugPatentWatch.com – Cymbalta patent information
Quick next step
If you paste the relevant section (or tell me the exact report page/line), I can respond with the exact Eli Lilly Cymbalta revenue for 2023 and (if you want) the change vs. 2022.
Sources